Transactions
10
Insider / AtriCure, Inc.
WEHRWEIN SVEN
Director at AtriCure, Inc.
- Company
- AtriCure, Inc.
- Ticker
- ATRC
- First filing on record
- November 26, 2025
- Latest trade on record
- July 28, 2026
- SEC filings
- EDGAR ↗
WEHRWEIN SVEN, Director at AtriCure, Inc., has disclosed 10 transactions in ATRC since November 26, 2025: 0 purchases (0 open-market buys) and 3 sales, worth about $2.0M at the reported prices. The latest was filed July 30, 2026, 2 days after the trade.
Open-market buys
0
Sales
3
Avg. disclosure lag
1.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months WEHRWEIN SVEN made no purchases and 3 sales worth $1.3M, plus 7 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
WEHRWEIN SVEN has traded 1 stock on record; the largest by dollars is ATRC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 6 | 70,000 | $698K |
| S | Open-market sale | 3 | 35,000 | $1.3M |
| A | Grant or award | 1 | 6,144 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 4 | 0 | 1 · $946K |
| 2025 | 6 | 0 | 2 · $377K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ATRC | Option / conversion M | July 28, 2026 | July 30, 2026 | 2d | 25,000 | — | — | derivative | Form 4 ↗ | |
| ATRC | Sell S | July 28, 2026 | July 30, 2026 | 2d | 25,000 | $38 | $946K | Form 4 ↗ | ||
| ATRC | Option / conversion M | July 28, 2026 | July 30, 2026 | 2d | 25,000 | $20 | $499K | Form 4 ↗ | ||
| ATRC | Other A | May 18, 2026 | May 20, 2026 | 2d | 6,144 | — | — | Form 4 ↗ | ||
| ATRC | Option / conversion M | November 25, 2025 | November 26, 2025 | 1d | 4,967 | — | — | derivative | Form 4 ↗ | |
| ATRC | Option / conversion M | November 24, 2025 | November 26, 2025 | 2d | 5,033 | — | — | derivative | Form 4 ↗ | |
| ATRC | Sell S | November 25, 2025 | November 26, 2025 | 1d | 4,967 | $38 | $189K | Form 4 ↗ | ||
| ATRC | Option / conversion M | November 25, 2025 | November 26, 2025 | 1d | 4,967 | $20 | $99K | Form 4 ↗ | ||
| ATRC | Sell S | November 24, 2025 | November 26, 2025 | 2d | 5,033 | $37 | $188K | Form 4 ↗ | ||
| ATRC | Option / conversion M | November 24, 2025 | November 26, 2025 | 2d | 5,033 | $20 | $100K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 30, 2026 | Form 4 | 0001205069-26-000005 | 3 | published | EDGAR ↗ |
| May 20, 2026 | Form 4 | 0001205069-26-000003 | 1 | published | EDGAR ↗ |
| November 26, 2025 | Form 4 | 0001205069-25-000007 | 6 | published | EDGAR ↗ |
Other insiders at AtriCure, Inc.
- Telman Deborah H Director 13 rows
- CARREL MICHAEL H President, CEO, & Director 10 rows
- Doraiswamy Vinayak Chief Scientific Officer 7 rows
- Privitera Salvatore Chief Technical Officer 7 rows
- Dahlquist Karl S. Chief Legal Officer 5 rows
- Noznesky Justin J Chief Mktg & Strategy Officer 5 rows
- Seith Douglas J Chief Operating Officer 5 rows
- Prange Karen Director 3 rows
- WHITE ROBERT S. Director 3 rows
- Wirick Angela L Chief Financial Officer 3 rows
Everyone on file, with contracts and lobbying under the company's name: AtriCure, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 10 | November 26, 2025 | July 30, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.